This study examined the impact of a restructured prior authorization process on the delivery of PBT at a proton therapy center.
Patients treated with chemotherapy plus radiotherapy had a 64% reduced likelihood of disease progression or death compared with those who underwent chemotherapy alone.
The purpose of this study was to develop and test a gene-expression profiling assay to facilitate patient selection for induction chemotherapy in the setting of LA-NPC.
Patients with low-grade serous carcinoma of the ovary or peritoneum (LGSC) developed chemoresistance to neoadjuvant platinum-based therapy.
Standardized triage process significantly improved timeliness of diagnosis and staging of suspected lung cancer at a rapid assessment clinic.
In men with nonmetastatic castration-resistant prostate cancer, a PSA doubling time of less than 3 months vs 15 months or more increases the risk of metastasis, which in turn is associated with a large increase in healthcare utilization and costs.
Multiparametric magnetic resonance imaging is highly accurate in differentiating nonmuscle-invasive from muscle-invasive bladder cancer, according to a new systematic review and meta-analysis.
Increased odds of adverse outcomes seen for Hispanic/Latinos, African-American Blacks versus white patients.
These guidelines were developed to facilitate decision-making regarding use of SAP in pediatric patients with cancer and children undergoing HSCT.
The effectiveness of using an educational video and booklet to improve patients’ expectations of cure from palliative chemotherapy was investigated in this study.
Clinicians are more likely to counsel younger and female patients on reproductive risks before initiating chemotherapy, despite available ASCO guidelines.
Pregnancy was not linked to differences in survival outcomes.
Vaccination with mRNA-1273, Moderna’s coronavirus disease 2019 (COVID-19) vaccine candidate, led to robust immune responses and protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in nonhuman primates.
Among patients with FLT3-internal tandem repeats, sorafenib maintenance therapy reduces the risk of relapse and death after allo-HSCT.
A literature search of new studies clarifies, refutes, and expands on previous recommendations for managing new and established CIPN in patients treated with cytotoxic agents.